Basic Information
ID: ALA4200654
Type: Functional
Description: Anticancer activity in patient with non-resectable locally advanced pancreatic cancer assessed as increase in 1 year survival at 400 mg/day, po co-administered with gemcitabine relative to gemcitabine alone
Organism: Homo sapiens
Activity Charts
Bioactivity
Activity Types for Assay ALA4200654
Activity
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 629.82 | 4.34 | 4.34 |